May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Validation of Rare Mitochondrial DNA Point Mutations Pathogenic for Leber’s Hereditary Optic Neuropathy (LHON)
Author Affiliations & Notes
  • L. Iommarini
    Neurological Sciences, University of Bologna, Bologna, Italy
  • A. Achilli
    Genetics and Microbiology, University of Pavia, Pavia, Italy
  • F. Pizza
    Neurological Sciences, University of Bologna, Bologna, Italy
  • C. La Morgia
    Neurological Sciences, University of Bologna, Bologna, Italy
  • M. L. Valentino
    Neurological Sciences, University of Bologna, Bologna, Italy
  • D. Bonneau
    Biochemistry and Genetics, University Hospital of Angers; INSERM U694, Angers, France
  • P. Amati-Bonneau
    Biochemistry and Genetics, University Hospital of Angers; INSERM U694, Angers, France
  • A. Torroni
    Genetics and Microbiology, University of Pavia, Pavia, Italy
  • V. Carelli
    Neurological Sciences, University of Bologna, Bologna, Italy
  • Footnotes
    Commercial Relationships  L. Iommarini, None; A. Achilli, None; F. Pizza, None; C. La Morgia, None; M.L. Valentino, None; D. Bonneau, None; P. Amati-Bonneau, None; A. Torroni, None; V. Carelli, None.
  • Footnotes
    Support  Supported by Telethon-Italy (grant# GGP06233 to VC)
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1308. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Iommarini, A. Achilli, F. Pizza, C. La Morgia, M. L. Valentino, D. Bonneau, P. Amati-Bonneau, A. Torroni, V. Carelli; Validation of Rare Mitochondrial DNA Point Mutations Pathogenic for Leber’s Hereditary Optic Neuropathy (LHON). Invest. Ophthalmol. Vis. Sci. 2008;49(13):1308.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : LHON is associated in 90% of patients with one of the three common mutations 11778/ND4, 3460/ND1 and 14484/ND6 (complex I subunit genes) in mitochondrial DNA (mtDNA). A small subset of LHON cases harbours different mtDNA mutations. We here describe and validate six rare LHON pathogenic mutations.

Methods: : We sequenced the entire mtDNA in eight probands, who fulfilled the criteria for being considered LHON patients. In each case a candidate pathogenic mutation was found, based on its absence from the known datasets of population specific polymorphisms, and being previously reported in association with LHON at least once. Protein sequences were obtained by a BLAST search and aligned by ClustalX. We calculated the percentage of amino acid conservation and we set the value of 70% as conservation threshold. We used the PolyPhen tool to predict the possible impact of an amino acid change.

Results: : We found the 14568/ND6 mutation in three cases (haplogroups U6a1, K1a and J1c), and the 14459/ND6 (J1c), 14495/ND6 (H), 10663/ND4L (L2a), 3700/ND1 (H), and 4171/ND1 (J2b) in each remaining patient. One of the 14568/ND6 cases, as well as the 14495/ND6 and 4171/ND1 cases were heteroplasmic. Three out of the eight LHON cases were on haplogroup J (37.5%, versus 7.2% in control European population). Considering all eukaryotic sequences only 2 mutations (14495/ND6 and 3700/ND1) were above the conservation threshold. However, conservation of all mutations increased going to vertebrates, and then only mammals. In the latter case the conservation for all mutations ranged between 97.6% and 100% (invariant position). PolyPhen predicted as probably damaging the 14459/ND6 and 14495/ND6 mutations, similar to the 11778/ND4 and 14484/ND6 classic pathogenic mutations.

Conclusions: : The 14568/ND6 mutation is the most frequent rare LHON pathogenic mutation. This study confirms that the ND6 gene is a mutational hot spot for LHON, and that the haplopgroup J is a modifying mtDNA background. All the other mutations were previously described at least once and this study validates their strict pathogenic association with LHON, suggesting their screening in LHON cases negative for the common mutations.

Keywords: mitochondria • mutations • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×